Global infections: 85,136,586
Change Over Yesterday: 533,729
Global deaths: 1,843,342
Nations with most cases: US (20,639,217), India (10,340,469), Brazil (7,733,746), Russia (3,203,743), France (2,712,975).
How pandemic will change travel in 2021
pandemic has upended the travel industry like no other, with sweeping restrictions forcing people to stay put and airlines posting huge losses. Just when countries began opening their borders to cross-border travel, the second and third waves threw a spanner into reopening plans. The new highly contagious coronavirus variant also forced several countries to impose severe curbs and suspend travel links, further dampening the prospects of safe traveling. However, as countries roll out vaccines, there is some relief in sight for the industry. This story tries to answer some of the most pressing queries facing the travel industry and individual travelers, from showing proof of immunity or vaccination to how long will it take for the industry to reach pre-pandemic levels. Read here
Palestinians excluded from Israeli vaccine rollout
Led by aggressive buying, a strongly digitised community-based health system and muscular central government, Israel's inoculation programme is powering ahead in terms of sheer vaccinations per day. But the drive is excluding Palestinians residing in the Israeli-occupied West Bank and Gaza as the vaccines are only given to Jewish settlers there. Meanwhile, Palestine is trying hard to secure vaccines through WHO-led initiative called Covax, which is aimed at helping poorer countries. Read here
Thousands in Pakistan line up to volunteer for Chinese vaccine trials
Vaccine scepticism runs deep in Pakistan, and has been a major problem for the country in eradicating diseases. However, thousands are queuing up to volunteer for Chinese vaccine trials, defying the country's long-held misconceptions and doubts over efficacy, safety of the vaccine. As is the case through out the pandemic, Pakistan
is depending on China
to innoculate its population. While Pakistan
has contained the outbreak better than immediate Asian neighbours such as India, the country is seeing a surge in infections in the second wave. This story chronicles how volunteers rose over inherent biases when it come to vaccines before participating in trials. Read here
Singaporeans won’t be able to choose between vaccines
starts its immunisation drive, its citizens aren't being allowed to choose from different vaccines available in the market, instead the government will decide, taking into account the number of vaccines available and after assessing which vaccine suits which group better, based on the medical history. Singapore
has already received its first batch of the Pfizer-BioNTech vaccine and has begun inoculating frontline health care workers. A recent survey showed that almost 60 per cent of people would get vaccinated if one was available in the country. Read here
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.